LACTO-N-NEOTETRAOSE Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White freeze-dried powder

Verwenden

Lacto-N-neotetraose (CAS# 13007-32-4) is a polysaccaride found in human milk. Oral supplementation of lacto-N-neotetraose in healthy adults resulted in shifts the intestinal microbiota - a substantial increase in relative abundance of actinobacteria and bifidobacterium and a reduction in the abundance of firmicutes and proteobacteria.

Definition

ChEBI: A tetrasaccharide comprising residues of galactose, N-acetylglucosamine, galactose and glucose in a linear sequence, all joined by beta-linkages.

LACTO-N-NEOTETRAOSE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LACTO-N-NEOTETRAOSE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Accela ChemBio Inc.	+1-858-6993322	info@accelachem.com	United States	19943	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
Zhengzhou Alfa Chemical Co.,Ltd	+8618530059196	sale04@alfachem.cn	China	13502	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38463	58
ShenZhen Trendseen Biological Technology Co.,Ltd.	13417589054	trendseenbio@gmail.com	China	11681	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52925	58
Hangzhou Yijing Technology Co., Ltd	15068777134	1289372011@qq.com	China	207	58
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Accela ChemBio Co.,Ltd.	021-50795510 4000665055	sales@accelachem.com	China	11655	64
Hunan Hui Bai Shi Biotechnology Co., Ltd.	0731-85526065 13308475853	ivy@hnhbsj.com	China	4552	62

13007-32-4()Verwandte Suche:

---

• N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
• Neolactotetraose
• LNnT, β-D-Gal-(1-4)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
• Lacto-N-neotetraose ,>=95%
• β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-D-Glc
• NLCOSE
• NLCOSE4
• lacto-N-neo-tetraose from human milk
• LNNT
• BETA-D-GAL-[1->4]-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
• GAL-BETA1,4GLCNA-CBETA1, 3GAL-BETA1, 4GLC
• LACTO-N-NEOTETRAOSE
• N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
• Lacto-N-neotetraose (LNnT / neo-LNT)
• D-Glucose, O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
• LNT/LNnT-mix[lacto-N-tetraose (type I chain)/lacto-N-neotetraose (type II chain)
• Galβ1,4GlcNAcβ1,3Galβ1,4Glc
• Lactulose Impurity 26
• Lacto-N-neotetraose / Core structure type 2(LNnT/ neoLNT)
• N-((2S,3R,4R,5S,6R)-2-(((2R,3S,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-4-yl)oxy)-4-hydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide
• 13007-32-4